Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis

被引:7
|
作者
Baral, Nischit [1 ]
Changezi, Hameem U. [2 ]
Khan, Mahin R. [3 ]
Adhikari, Govinda [4 ]
Adhikari, Prakash [5 ]
Khan, Hafiz Muhammad Waqas [3 ]
Poudyal, Abhushan [6 ]
Abdelazeem, Basel [1 ]
Sigdel, Shashi [7 ]
Champine, Andrew [8 ]
机构
[1] McLaren Flint Michigan State Univ MSU, Internal Med, Flint, MI 48502 USA
[2] McLaren Flint Michigan State Univ MSU, Cardiovasc Med, Flint, MI USA
[3] McLaren Flint Michigan State Univ MSU, Cardiol, Flint, MI USA
[4] McLaren Flint, Internal Med, Flint, MI USA
[5] Piedmont Athens Reg Med Ctr, Internal Med, Athens, GA USA
[6] Cook Cty Hlth, Cardiovasc Med, Chicago, IL USA
[7] Rochester Reg Hlth, Internal Med, Rochester, NY USA
[8] McLaren Flint Michigan State Univ MSU, Behav Hlth Family Med Intemal Med, Flint, MI USA
关键词
inspiratory muscle training; heart failure with preserved election fraction; respiratory muscle exercise; diastolic heart failure; peak oxygen consumption; 6 minute walk distance; WEAKNESS; CAPACITY;
D O I
10.7759/cureus.12260
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To explore the role of inspiratory muscle training (IMT) in improving cardiorespiratory fitness of stable heart failure with preserved ejection fraction (HFpEF) patients. Background There is a paucity of data on the role of IMT in patients with HFpEF. HFpEF is a growing problem in the developed world, especially in the aging population. Methods We conducted a systematic literature search for English studies in PubMed, EMBASE, and Cochrane Central Register of Controlled Trials. We searched databases using terms relating to or describing breathing exercise, IMT, and HFpEF. RevMan 5.4 (The Cochrane Collaboration, 2020) was used for data analysis, and two independent investigators performed literature retrieval and data extraction. Results We identified three randomized controlled trials (RCTs) and one prospective study on the role of IMT in HFpEF. We calculated the pooled mean difference of peak oxygen consumption (Peak VO2) and six-min walk distance (6MWD) between the IMT and standard care (SC) groups. Our meta-analysis showed that compared with SC, IMT could significantly improve peak Vol with a mean difference (MD) of 2.82 ml/kg/min, 95% CI [1.90, 3.74]P < 0.00001 and improve 6MWD with MD of 83.97 meters, 95% CI [59.18, 108.76] P< 0.00001 to improve cardiorespiratory fitness at 12 weeks of IMT and improve peak VO2 with MD of 2.18 ml/kg/min, 95% CI [0.38, 3.99] P < 0.00001 at 24 weeks of therapy. Conclusion IMT should be further studied as a possible treatment option to improve cardiorespiratory fitness for patients with stable HFpEF.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
    Sobral, Milene Vitoria Sampaio
    Rodrigues, Livia Kneipp
    Barbosa, Abner Macola Pacheco
    da Rocha, Naila Camila
    Moulaz, Isac Ribeiro
    dos Santos, Joao Pedro Pereira
    Oliveira, Bruno Henrique Couto
    Moreira, Joao Lucas de Magalhaes Leal
    Pacagnelli, Francis Lopes
    Guida, Camila Mota
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025,
  • [42] EFFICACY OF PHOSPHODIESTERASE-5 INHIBITOR IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A META-ANALYSIS
    Bajaj, Anurag
    Nanavaty, Sukrut
    Coppola, John
    Tiwari, Hemant
    Patel, Tejas
    Pancholy, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 704 - 704
  • [43] Pharmacotherapies in Heart Failure With Preserved Ejection Fraction A Systematic Review and Network Meta-Analysis
    Sreenivasan, Jayakumar
    Malik, Aaqib
    Khan, Muhammad Shahzeb
    Lloji, Amanda
    Hooda, Urvashi
    Aronow, Wilbert S.
    Lanier, Gregg M.
    Pan, Stephen
    Greene, Stephen J.
    Murad, M. Hassan
    Michos, Erin D.
    Cooper, Howard A.
    Gass, Alan
    Gupta, Rahul
    Desai, Nihar R.
    Mentz, Robert J.
    Frishman, William H.
    Panza, Julio A.
    CARDIOLOGY IN REVIEW, 2024, 32 (02) : 114 - 123
  • [44] Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis
    Chen, Zhu
    Zhao, Kaixuan
    Xiao, Changhu
    He, Ziyu
    Liu, Sha
    Wu, Xuemei
    Shi, Shuting
    Guo, Yuan
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (08) : 1079 - 1087
  • [45] Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis
    Beale, Anna L.
    Warren, Josephine Lillian
    Roberts, Nia
    Meyer, Philippe
    Townsend, Nick P.
    Kaye, David
    OPEN HEART, 2019, 6 (01):
  • [46] The prognostic significance of heart failure with preserved ejection fraction: a meta-analysis of prospective studies
    Whalley, G. A.
    Berry, C.
    Somaratne, J. B.
    Mcmurray, J.
    Doughty, R. N.
    EUROPEAN HEART JOURNAL, 2007, 28 : 271 - 271
  • [47] Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
    Mei Jun
    Xu Hao
    Xu Feng-qin
    Ju Jian-qing
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (10) : 770 - 777
  • [48] Digoxin and Outcomes in Patients with Heart Failure and Preserved Ejection Fraction (HFpEF) Patients: A Systematic Review and Meta-Analysis
    Hashemi-Shahri, Seyed H.
    Aghajanloo, Ali
    Ghavami, Vahid
    Arasteh, Omid
    Mohammadpour, Amir H.
    Reiner, Zeljko
    Sahebkar, Amirhossein
    CURRENT DRUG TARGETS, 2023, 24 (02) : 191 - 200
  • [49] Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
    MEI Jun
    XU Hao
    XU Feng-qin
    JU Jian-qing
    Chinese Journal of Integrative Medicine , 2019, (10) : 770 - 777
  • [50] Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-analysis
    Satish, Mohan
    Guddeti, Raviteja
    Wenzl, Florian
    Walters, Ryan
    Alla, Venkata M.
    CIRCULATION, 2020, 142